Out of the Blue: An AJRCCM Podcast

American Thoracic Society

Obstructive Sleep Apnea

Interstitial Lung Disease

Respiratory Medicine

Chronic Lung Disease

Home-Based Monitoring

Familial Pulmonary Fibrosis

Patient Care

Clinical Trials

Covid-19

Pulmonary Fibrosis

Hypnotics

Arousal Threshold

Health Equity

Digital Health Literacy

Fleishner Society

Tuberculosis

Idiopathic Pulmonary Fibrosis

Clinical Guidelines

Fibrotic Interstitial Lung Disease

Cough

The Out of the Blue podcast takes you out of the pages of the American Journal of Respiratory and Critical Care Medicine and into the minds of the most brilliant researchers in the fields of respiratory, critical care, and sleep medicine.

57 ratings

Publishes	Monthly	Episodes	184	Founded	15 years ago
Number of Listeners		Categories	Life SciencesHealth & FitnessMedicineScience

Listen to this Podcast

Guests Hosts Reviews Charts Talking Points

Latest Episodes

Temporary Transvenous Diaphragm Neurostimulation for Weaning from Mechanical Ventilation (RESCUE-3)

Dr. Michael Lanspa chats with Dr. Ewan Goligher about his article, "Temporary Transvenous Diaphragm Neurostimulation for Weaning from Mechanical Ventilation (RESCUE-3)."

11 Sep 2025 • 35 min

Performance Characteristics for Physiological Measures of Progressive Pulmonary Fibrosis and Progress in Progressive Pulmonary Fibrosis

Dr. Mohleen Kang chats with Dr. Justin Oldham, Dr. Chad Newton and Dr. Jesse Roman about their papers, "Performance Characteristics for Physiological Measures of Progressive Pulmonary Fibrosis" and "Progress in Progressive Pulmonary Fibrosis."

4 Sep 2025 • 21 min

Approach to the Evaluation and Management of Interstitial Lung Abnormalities

Dr. Mohleen Kang chats with Dr. Anna Podolanczuk and Dr. Gary Hunninghake about their article, "Approach to the Evaluation and Management of Interstitial Lung Abnormalities."

17 Jul 2025 • 30 min

Camlipixant in Refractory Chronic Cough: A Phase 2b, Randomized, Placebo-controlled Trial (SOOTHE)" and "Camlipixant: A New Hope for Refractory Chronic Cough?

Dr. John Fleetham chats with Dr. Jaclyn Smith and Dr. Imran Satia about their articles, "Camlipixant in Refractory Chronic Cough: A Phase 2b, Randomized, Placebo-controlled Trial (SOOTHE)" and "Camlipixant: A New Hope for Refractory Chronic Cough?"

10 Jul 2025 • 28 min

Key Facts

Accepts Guests

Accepts Sponsors

Contact Information

Podcast Host

Number of Listeners

Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

ATS Breathe EasyAmerican Thoracic Society

CHEST Journal PodcastsAmerican College of Chest Physicians

Critical Care TimeCritical Care Time Podcast

JAMA Clinical ReviewsJAMA Network

Critical Care ScenariosBrandon Oto, PA-C, FCCM and Bryan Boling, DNP, ACNP, FCCM

Recent Guests

Dr. Ewan Goligher

Associate professor in the Interdepartmental Division of Critical Care Medicine at University of Toronto and Senior Scientist at the Toronto General Hospital Research Institute

University of Toronto

Episode: Temporary Transvenous Diaphragm Neurostimulation for Weaning from Mechanical Ventilation (RESCUE-3)

Dr. Martin Dress

Lead author of the study referenced in the podcast

Episode: Temporary Transvenous Diaphragm Neurostimulation for Weaning from Mechanical Ventilation (RESCUE-3)

Chad Newton

Associate Professor of Medicine at UT Southwestern Medical Center and Associate Director of UT Southwestern's Interstitial Lung Disease Program

UT Southwestern Medical Center

Episode: Performance Characteristics for Physiological Measures of Progressive Pulmonary Fibrosis and Progress in Progressive Pulmonary Fibrosis

Justin Oldham

Clinical Associate Professor at the University of Michigan Medicine and Director of ILD Research there

University of Michigan Medicine

Episode: Performance Characteristics for Physiological Measures of Progressive Pulmonary Fibrosis and Progress in Progressive Pulmonary Fibrosis

Jesse Roman

Professor of Medicine at Thomas Jefferson University and current ATS Secretary

Thomas Jefferson University

Episode: Performance Characteristics for Physiological Measures of Progressive Pulmonary Fibrosis and Progress in Progressive Pulmonary Fibrosis

Gary Mat Hunninghake

Director of the ILD program at Brigham and Women's Hospital and Watkins Family Endowed Professor of Autoimmune Interstitial Lung Disease at Harvard Medical School.

Brigham and Women's Hospital

Episode: Approach to the Evaluation and Management of Interstitial Lung Abnormalities

Dr. Jaclyn Smith

Senior Author on the recent Camlipixant trials

University of Manchester

Episode: Camlipixant in Refractory Chronic Cough: A Phase 2b, Randomized, Placebo-controlled Trial (SOOTHE)" and "Camlipixant: A New Hope for Refractory Chronic Cough?

Dr. Imran Satia

Co-writer of the Associated Editorial

McMaster University

Episode: Camlipixant in Refractory Chronic Cough: A Phase 2b, Randomized, Placebo-controlled Trial (SOOTHE)" and "Camlipixant: A New Hope for Refractory Chronic Cough?

Carmen Reep

Data scientist at Erasmus Medical Center in Rotterdam

Erasmus Medical Center

Episode: Early vs. Delayed Switching from Controlled to Assisted Ventilation: A Target Trial Emulation

Hosts

Mohleen Kang

Assistant Professor of Medicine with expertise in respiratory medicine, currently engaged in educational outreach and research initiatives.

John Fleetham

A Professor of Medicine specializing in respiratory medicine, focused on clinical practices and the advancement of medical education.

Michael Lanspa

Host and expert in respiratory and critical care medicine, involved in furthering clinical understanding and medical education.

Reviews

4.2 out of 5 stars from 57 ratings

Amazing Content!
The ATS does such a good job covering a variety of topics. The guests offer valuable insight as well. I would recommend this podcast to anyone looking to be inspired and informed!
Apple Podcasts
5
megan@podcastingyou
United States4 years ago
Grear option for respiratory care physicians
Great!
Apple Podcasts
5
Ricardo Bandeira Filho
Brazil7 years ago

Embed These Reviews on a Website

Listeners Say

Key themes from listener reviews, highlighting what works and what could be improved about the show.

Listeners appreciate the insightful discussions and expertise shared by guests, making complex topics accessible and engaging.

Many find the content inspiring and informative, particularly valuing the relevance to their professional practices.

Chart Rankings

How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.

Apple Podcasts	#39	Colombia/Health & Fitness/Medicine
Apple Podcasts	#211	India/Health & Fitness/Medicine
Apple Podcasts	#213	Japan/Health & Fitness/Medicine
Apple Podcasts	#217	Finland/Health & Fitness/Medicine
Apple Podcasts	#219	Taiwan/Health & Fitness/Medicine
Apple Podcasts	#241	Singapore/Health & Fitness/Medicine

Talking Points

Recent interactions between the hosts and their guests.

Temporary Transvenous Diaphragm Neurostimulation for Weaning from Mechanical Ventilation (RESCUE-3)

Q: What are the safety concerns associated with diaphragm neurostimulation?

Safety data indicated a higher rate of serious adverse events in the intervention group compared to control, primarily linked to complications like infection and cardiac issues.

Temporary Transvenous Diaphragm Neurostimulation for Weaning from Mechanical Ventilation (RESCUE-3)

Q: How is the diaphragm neurostimulation delivered?

The diaphragm neurostimulation was delivered using a transvenous approach, involving a specially equipped central venous catheter to stimulate the phrenic nerves.

Temporary Transvenous Diaphragm Neurostimulation for Weaning from Mechanical Ventilation (RESCUE-3)

Q: What was the primary outcome of the RESCUE-3 trial?

The primary outcome was successful weaning at day 30, defined as remaining off the ventilator for at least 48 hours, showing a strong probability of benefit from diaphragm neurostimulation.

Temporary Transvenous Diaphragm Neurostimulation for Weaning from Mechanical Ventilation (RESCUE-3)

Q: How common is diaphragmatic dysfunction?

Diaphragmatic dysfunction is very common in mechanically ventilated patients, with studies indicating that about two-thirds of such patients exhibit it at the first spontaneous breathing trial.

Performance Characteristics for Physiological Measures of Progressive Pulmonary Fibrosis and Progress in Progressive Pulmonary Fibrosis

Q: Should we redefine the criteria for progressive pulmonary fibrosis to focus more on sensitivity or specificity?

We need to redefine PPF criteria to have a sensitive marker to identify at-risk patients for early intervention, especially since effective treatments for PPF exist.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About Out of the Blue: An AJRCCM Podcast

What is Out of the Blue: An AJRCCM Podcast about and what kind of topics does it cover?

Focused on respiratory and critical care medicine, this podcast provides deep insights into various aspects of pulmonary health and critical patient care. It features discussions among leading experts in the field, addressing pertinent topics such as progressive pulmonary fibrosis, interstitial lung disease, chronic cough management, and the impact of environmental exposures on lung health. The conversations not only highlight the latest research findings but also explore clinical guidelines and practical implications for healthcare professionals, making it a vital resource for those interested in contemporary medical practices in these specialties.

Where can I find podcast stats for Out of the Blue: An AJRCCM Podcast?

Rephonic provides a wide range of podcast stats for Out of the Blue: An AJRCCM Podcast. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to Out of the Blue: An AJRCCM Podcast and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does Out of the Blue: An AJRCCM Podcast get?

Rephonic provides a full set of podcast information for three million podcasts, including the number of listeners. View further listenership figures for Out of the Blue: An AJRCCM Podcast, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for Out of the Blue: An AJRCCM Podcast?

Rephonic provides comprehensive predictive audience data for Out of the Blue: An AJRCCM Podcast, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does Out of the Blue: An AJRCCM Podcast have?

To see how many followers or subscribers Out of the Blue: An AJRCCM Podcast has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to Out of the Blue: An AJRCCM Podcast?

These podcasts share a similar audience with Out of the Blue: An AJRCCM Podcast:

1. ATS Breathe Easy
2. CHEST Journal Podcasts
3. Critical Care Time
4. JAMA Clinical Reviews
5. Critical Care Scenarios

How many episodes of Out of the Blue: An AJRCCM Podcast are there?

Out of the Blue: An AJRCCM Podcast launched 15 years ago and published 184 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact Out of the Blue: An AJRCCM Podcast?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for Out of the Blue: An AJRCCM Podcast?

Rephonic pulls ratings and reviews for Out of the Blue: An AJRCCM Podcast from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for Out of the Blue: An AJRCCM Podcast?

Rephonic provides full transcripts for episodes of Out of the Blue: An AJRCCM Podcast. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on Out of the Blue: An AJRCCM Podcast?

Recent guests on Out of the Blue: An AJRCCM Podcast include:

1. Dr. Ewan Goligher
2. Dr. Martin Dress
3. Chad Newton
4. Justin Oldham
5. Jesse Roman
6. Gary Mat Hunninghake
7. Dr. Jaclyn Smith
8. Dr. Imran Satia

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.

Try it free for 7 days